Cultured cells were subsequently analyzed by reverse-transcription polymerase chain reaction (RT-PCR) analysis, WB, light microscopy and immunofluorescence for the expression PDX1, neurogenin3 (NGN3), musculoaponeurotic fibrosarcoma oncogene homolog A (MAFA), or pancreatic hormones insulin (INS), glucagon (GLU), and somatostatin (SST). Furthermore, cells were analyzed, by Enzyme Linked Immuno-sorbent Assay (ELISA) for c-peptide production in response to high glucose. Results: The western blotting and spectroscopy analyses confirmed the efficient production by
bacterial cells of a purified PDX1 protein (43 kDa) corresponding to the primary structure of the human PDX1. Purified PDX1 protein internalized efficiently in hBTSCs. Cell viability Selleckchem SAHA HDAC remained stable in cultures exposed to [0.1 μM] PDX1, while it decreased at [0.5 μM] PDX1 concentration. PDX1 peptide exposure triggered the expression of both intermediate transcriptional factors (MAFA, NGN3, endogenous PDX1 itself) and mature stage pancreatic islet cell differentiation markers (INS, GLU, STT). Furthermore, hBTSC cultures exposed to PDX1 showed a tridimensional GSI-IX purchase growing islet-like structures constituted by densely packed cells intensely positive for PDX1, c-peptide, INS, GLU and STT. Finally, these PDX1 peptide-induced islet like structures exhibited glucose-dependent capability to secrete c-peptide. Conclusions:
The newly synthesized human PDX1 peptide efficiently reprogrammed hBTSCs to functional p-pancreatic islet cells with important implications for the regenerative medicine of pancreatic diseases and diabetes. Disclosures: The following people have nothing to disclose: this website Vincenzo Cardinale, Gaia Scafetta, Rosa Puca, Michele De
Canio, Francesca Sicilia, Guido Carpino, Domenico Casa, Rocco C. Panetta, Pasquale Bartolomeo Berloco, Giorgio Fed-erici, Eugenio Gaudio, Marella Maroder, Domenico Alvaro Aim: hBTSCs are candidate for regenerative medicine of liver and pancreas. Recently, freshly isolated hBTSCs have been transplanted in patients with advanced liver cirrhosis. The aim of this study was to identify the best strategy for the cryopres-ervation of hBTSCs. Methods: Epithelial Cell Adhesion Molecule (EpCAM) positive hBTSCs were immunoselected from liver donors, and transferred into serum-free Kubota’s Medium (KM). Thereafter, the cells were subjected to a gradual controlled cryopreservation (1°C/min down to −196°C in liquid nitrogen) in serum-free solutions containing 10% dimethyl-sulf-oxide (DMSO) and different concentrations of human albumin and/or synthetic human hyaluronic acid (HA). Thawed cells were assessed for viability, senescence by X-gal test, population doubling, expression of different genes (CD44, ITGB1, ITGB4, CDH1, PDX1, SOX17, OCT4 by RT-PCR), platting efficiency, engraftment, CD44-HA binding, and differentiation potential. Results: Solutions containing 15% albumin + 0.1% HA (Sol1) and solutions containing 15% albumin (Sol3) determined higher cell viability (77.